Article
A novel de novo mutation in COL1A1 leading to osteogenesis imperfecta confirmed by zebrafish model.
Clinica chimica acta; international journal of clinical chemistry - 1 Jun 2021
Huang Huan, Liu Jiamei, Zhang Guoying
Abstract excerpt
Our study reports a novel dominant COL1A1 mutation in OI. Using a zebrafish model, we confirmed that the glycine to serine substitution at position 608 of the COL1A1 protein has deleterious effects on bone development. PURPOSE: Osteogenesis imperfecta (OI), also known as brittle bone disease, is a group of genetic disorders. Mutations in two genes, collagen type I alpha 1 chain (COL1A1) and collagen type I alpha...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
